↓ Skip to main content

Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer

Overview of attention for article published in Anti-Cancer Drugs, July 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

blogs
1 blog
twitter
5 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer
Published in
Anti-Cancer Drugs, July 2019
DOI 10.1097/cad.0000000000000794
Pubmed ID
Authors

Ignacio Romero, Pedro Mallol, Ana Santaballa, Jose M. Del Campo, Marta Mori, Santiago González-Santiago, Antonio Casado, David Vicente, Eugenia Ortega, Ana Herrero, Eva Guerra, Pilar Barretina-Ginesta, María J. Rubio, Alejandro Martínez, Isabel Bover, Laura Vidal, Ángels Arcusa, Lola Martín, Yolanda García, Antonio González-Martín

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 13%
Student > Ph. D. Student 3 13%
Researcher 3 13%
Student > Master 2 8%
Other 1 4%
Other 2 8%
Unknown 10 42%
Readers by discipline Count As %
Medicine and Dentistry 7 29%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Biochemistry, Genetics and Molecular Biology 1 4%
Psychology 1 4%
Agricultural and Biological Sciences 1 4%
Other 2 8%
Unknown 10 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2019.
All research outputs
#4,113,686
of 25,385,509 outputs
Outputs from Anti-Cancer Drugs
#87
of 1,836 outputs
Outputs of similar age
#77,122
of 363,724 outputs
Outputs of similar age from Anti-Cancer Drugs
#2
of 13 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,836 research outputs from this source. They receive a mean Attention Score of 2.4. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,724 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.